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Insulin signaling depends on tyrosine phosphorylation of insulin receptor substrates (IRSs) to mediate downstream eﬀects;
however, elevated serine phosphorylation of IRS impairs insulin signaling. Here, we investigated IRS protein expression patterns
in dorsal root ganglia (DRG) of mice and whether their signaling was aﬀected by diabetes. Both IRS1 and IRS2 are expressed in
DRG; however, IRS2 appears to be the prevalent isoform and is expressed by many DRG neuronal subtypes. Phosphorylation of
Ser(731)IRS2 was signiﬁcantly elevated in DRG neurons from type 1 and type 2 diabetic mice. Additionally, Akt activation and
neurite outgrowth in response to insulin were signiﬁcantly decreased in DRG cultures from diabetic ob/ob mice. These results
suggest that DRG neurons express IRS proteins that are altered by diabetes similar to other peripheral tissues, and insulin signaling
downstreamoftheinsulinreceptormaybeimpairedinsensoryneuronsandcontributetothepathogenesisofdiabeticneuropathy.
1.Introduction
Diabetic neuropathy is the most common complication of
diabetes, aﬀecting 50% of patients [1]. Many patients suﬀer
from decreased proprioception and peripheral insensitivity,
causing foot injuries and falls. Alternatively, a subset of
patients develop allodynia and chronic nerve pain [2].
DN is caused by a “dying back” of peripheral nerve ﬁbers
and is associated with axonal degeneration of the long
axons innervating the extremities [2]. The pathology of
DN is driven by multiple mechanisms, including decreased
neurotrophic support [2–4], increased polyol ﬂux [2, 3, 5],
advanced glycation end products [2, 3, 5], mitochondrial
dysfunction [6], and oxidative stress [2, 3, 5].
Although insulin signaling does not seem to regulate
glucose uptake in neurons as it does in muscle and adipose
tissue [7], insulin does appear to be crucial for proper
neuron function both in vitro and in vivo.C u r r e n tv i e w s
now include insulin as a potent neurotrophic factor that
supports neuronal growth, survival, plasticity, and mainte-
nance of diﬀerentiated neurons [8–14]. Insulin signaling is
propagated by a series of phosphorylation events that rely
on a cytoplasmic docking protein known as insulin receptor
substrate (IRS). Following insulin binding to the insulin
receptor, intrinsic kinase activity phosphorylates tyrosine
residues on both the insulin receptor and IRS. Tyrosine
phosphorylation allows downstream mediators with src
homology 2 (SH2) domains to bind IRS and localize to the
plasma membrane. Two key SH2-containing mediators are
PI3-kinase, which activates the Akt cascade, and Grb2/Sos,
which activates the Ras cascade [15, 16]. These eﬀectors
drive increased transcription, translation, and translocation
of proteins associated with insulin’s actions.
Four mammalian isoforms of IRS have been described
thus far, with IRS1 and IRS2 being the most physiologically
relevant [17, 18]. IRS1 appears to be the main isoform
expressed in muscle and adipose tissue [17–19], whereas
IRS2seemstobemorerelevantinliverandbrain[17,18,20].
Mice with systemic IRS1 knockouts demonstrate growth
retardation, insulin resistance, and beta-cell hyperplasia
without diabetes [18]. IRS2 knockout mice develop insulin
resistance, decreased beta-cell proliferation, overt diabetes,
and female sterility [17, 18].
Serine phosphorylation of IRS has emerged as a key
regulatorystepforinsulinsignalinginbothphysiologicaland
pathological situations. A large body of work suggests that
elevated IRS serine phosphorylation inhibits insulin signal
transduction [15, 16, 19, 21–28]. Under normal conditions,2 Experimental Diabetes Research
IRS is tyrosine phosphorylated upon insulin binding, but,
following accumulation of activated downstream media-
tors, IRS is phosphorylated on serine residues, impairing
insulin signaling through a negative feedback mechanism.
In an insulin-resistant state, agents that promote IRS serine
phosphorylation are upregulated, resulting in pathological
elevationofIRSserinephosphorylationandimpairedinsulin
signaling [15, 16, 21, 22, 27–30].
To address whether these same regulatory mechanisms
aﬀect sensory neurons, we examined IRS expression and
signaling in vivo and in vitro in DRG neurons from
streptozotocin- (STZ-) induced type 1 and ob/ob type 2
diabetic mice. Our results suggest that IRS proteins are
expressed by sensory DRG neurons and undergo elevated
serine phosphorylation in diabetic mice. Cultured DRG
neuronsfromob/obanimalshadbluntedresponsestoinsulin
as indicated by decreased Akt activation and neurite out-
growth. These ﬁndings support the hypothesis that insulin
resistance due to increased serine phosphorylation of IRS2
could contribute to alterations in neuronal insulin support
and promote peripheral nerve dysfunction.
2.MaterialsandMethods
2.1. Animals. All experiments were approved by The Univer-
sity of Kansas Medical Center Institutional Animal Care and
Use Committee. Mice were subjected to a 12-hour light/dark
cycle and had ad libitum access to food and water. For
determination of IRS expression, 8-week-old male C57Bl/6
mice were purchased from Charles River (Wilmington,
Mass, USA). DRG were harvested for reverse transcriptase-
PCR, Western blot analysis, and immunohistochemistry. To
determine the eﬀects of diabetes on insulin signaling in
peripheral neurons, male ob/ob mice and colony controls
were ordered at 8 weeks of age from Jackson Laboratories
(Bar Harbor, Maine). The ob/ob leptin knockout animals
have been previously characterized as a model of insulin
resistance, type 2 diabetes, and DN [31].
Inaddition,diabeteswasinducedin8-week-oldC57BL/6
male mice using a single intraperitoneal injection of strepto-
zotocin (STZ), a pancreatic beta-cell toxin (Sigma, St. Louis,
Mo), at 180mg/kg body weight. The STZ was dissolved in
10mM sodium citrate buﬀer (pH 4.5) and the nondiabetic
mice were injected with 400μL of the vehicle buﬀer. Mice
were fasted for 3 hours before and after injection to improve
STZ uptake in pancreatic β cells.
Body weights and blood glucose levels via tail clip were
checked weekly to monitor diabetes progression. For both
type 1 and type 2 models, hyperglycemia and diabetes was
deﬁned as a blood glucose level greater than 16mM (∼
288mg/dL). All STZ-injected mice with blood glucose levels
below 288mg/dL were removed from the study.
2.2. Adult DRG Culture. Mice were anesthetized with an
intraperitoneal (i.p.) injection of cold avertin (2-2-2 Tribro-
moethanol) 20μLg −1 and transcardially perfused with ice-
cold HBSS without Ca++/Mg++ (Sigma-Aldrich) to reduce
protease activity and increase cell survival [32]. The DRG
were harvested and transferred to 3mL of ice-cold HBSS
without Ca++/Mg++. Adult mouse DRG were cultured
according to a protocol published by Malin et al. [32]. All
procedureswereperformedinatissuehoodwithappropriate
steriletechnique.DRGwerepartiallydigestedwith2separate
enzyme solutions, one containing papain (Worthington,
Lakewood, NJ, USA) and another containing collagenase
type II (Worthington) and dispase type II (Roche, Basel,
Switzerland). Neurons were then triturated with a ﬁre-
polished glass Pasteur pipette to dissociate neuronal cell
bodies. Neurons were grown on Laminin/poly-D-lysine-
coated coverslips (BD Biosciences, Bedford, MA) placed in
24-well culture plates (Sigma-Aldrich). The media consisted
of insulin-free B27 supplement (Invitrogen, Carlsbad, Calif,
USA), penicillin/streptomycin (Invitrogen), and F12 culture
medium (Invitrogen). Neurons were then allowed to adhere
to coverslips for 2 hours. After this time, either 1mL fresh
insulin-free media or media containing 100nM insulin
(Sigma-Aldrich), depending on the experimental group and
assay were added. For hyperglycemia experiments, DRG
neuronal cultures from wild-type C57Bl/6 mice were grown
in 25mM glucose and control cultures were maintained at
10mM glucose based [33, 34].
2.3. Reverse Transcriptase Polymerase Chain Reaction. RT-
PCR was performed to determine mRNA levels of diﬀerent
IRS isoforms. Total RNA was isolated from DRG tissue
using TRI Reagent (Ambion, Foster City, CA) as indicated
in the manufacturer’s protocol. The RNA concentration
was determined using a Bio-Rad spectrophotometer, and
the quality of RNA was tested with an electrophoretic
separation technique (Agilent 2100 bioanalyzer tracer with
theEukaryoteTotalRNANanoAssay).RNAwasthenreverse
transcribed to cDNA using iScript cDNA synthesis kit (Bio-
Rad). The thermal cycler conditions were as follows: 25◦C
for 5 minutes, 42◦Cf o r3 0m i n u t e s ,a n d8 5 ◦Cf o r5m i n u t e s .
Real-time PCR ampliﬁcation of IRS1, IRS2, IRS3, and IRS4
was performed using 2.0μg of cDNA and SYBR green master
mix (Bio-Rad). Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH)wasusedasareferencegene,andallreactionswere
run in triplicate. The thermal cycler conditions for PCR were
95◦Ca n d6 0 ◦C for 40 cycles. The primer sequences used for
real-time PCR were as follows:
IRS1 forward: 5 -CTCTACACCCGAGACGAACAC-3 
IRS1 reverse: 5 -TGGGCCTTTGCCCGATTATG-3 
IRS2 forward: 5 -CTGCGTCCTCTCCCAAAGTG-3 
IRS2 reverse: 5 -GGGGTCATGGGCATGTAGC-3 
IRS3 forward: 5 -TCCTCCAAAGAGTGTTCCTGC-3 
IRS3 reverse: 5 -GGGGCTTGAAGTAGTCCTGC-3 
IRS4 forward: 5 -TCCTGTACCAATGCTTCTCCG-3 
IRS4 reverse: 5 -AGCTTTCTTGTTCCGACTCGT-3 
GAPDH forward: 5 -AGGTCGGTGTGAACGGAT-
TTG-3 
GAPDH reverse: 5 -TGTAGACCATGTAGTTGAGG-
TCA-3 
IRS isoform mRNA levels were normalized to GAPDH,
and the ΔΔCt method was used for relative expression
analysis.Experimental Diabetes Research 3
2.4. Western Blots. DRG were harvested and frozen at −80◦C
until further use. Tissue was sonicated in Cell Extraction
Buﬀer (CEB) (Invitrogen) containing 55.55μL/mL protease
inhibitor cocktail, 200mM Na3VO4, and 200mM NaF.
P r o t e i nf r o mp r i m a r yD R Gc u l t u r e sw a sh a r v e s t e da f t e r
3 days in insulin-free media by removing growth media,
adding CEB (Invitrogen), and then scraping the coverslips.
Three coverslips per treatment group were combined into a
single sample. The samples were incubated on ice for 1 hour
withlightvortexingevery10minutesandthencentrifugedat
7000rpmfor10minutesat4◦C. Proteinconcentrationofthe
supernatant was measured with a Bradford assay (Bio-Rad,
Hercules, CA). Samples were then boiled with Lane Marker
Reducing Sample Buﬀer (Thermo Scientiﬁc, Waltham, MA)
for 3 minutes. For normalization purposes, equal amounts
of protein were loaded for each sample. The samples were
separatedona4–15%gradienttris-glycinegel(Bio-Rad)and
thentransferredtoanitrocellulosemembrane.Aftertransfer,
the membrane was stained with Ponceau S and cut so that
IRS (180kDA) and Akt (60kDA) are separated, producing
2 membranes that could be probed independently. Primary
antibodies were used at the following dilutions and incu-
bations: total IRS1 (Santa Cruz, Santa Cruz, CA) 1:1000
overnight at 4◦C, total IRS2 (Millipore, Billerica, MA) 1:500
overnight at 4◦C, pSer(731)IRS2 (Abcam, Cambridge, MA)
1:1000 overnight at 4◦C, insulin receptor β subunit (Santa
Cruz) 1:500 overnight at 4◦C, pSer(473)Akt (Cell Signaling,
Danvers, MA) 1:500 overnight at 4◦C, total Akt (Cell Signal-
ing)1:500overnightat4◦C,andactin(Millipore)1:100,000
at room temperature for 1 hour. Antimouse and antirabbit
secondary antibodies conjugated to HRP (Santa Cruz)
were diluted 1:10,000 and incubated for 1 hour at room
temperature. Band density was analyzed with ImageJ (NIH).
2.5. Immunohistochemistry. DRG were harvested and imme-
diately frozen in Tissue Tek (Sakura Finetek, Torrance, CA).
The tissue was sectioned at 10μm with a cryostat and placed
in serial order on glass slides. Slides were blocked at room
temperature for 1 hour with preincubation solution (1.5%
Normal Goat or Donkey Serum, 0.5% Porcine Gelatin, 0.5%
Triton X-100, and 450μL Superblock (Thermo Scientiﬁc)).
Primary antibodies were used at the following dilutions
and incubations: total IRS2 (Millipore) 1:400 overnight
at 4◦C, mouse monoclonal Peripherin (Millipore) 1:2000
overnight at 4◦C, and mouse monoclonal Neuroﬁlament 200
(Sigma) 1:2000 overnight at 4◦C. Donkey antirabbit Alexa-
488 and donkey antimouse Alexa-555 conjugated secondary
antibodies (Invitrogen) were diluted 1:2000 and incubated
for 1 hour at 4◦C. Images were photographed using a Nikon
Eclipse E800 microscope and analyzed with ImageJ (NIH).
2.6. Neurite Outgrowth. To assess potential changes in the
functional neurotrophic eﬀect of insulin on DRG neurons,
neurite outgrowth was quantiﬁed in dissociated cultures of
ob/ob mice and controls. After 5 days in culture with either
insulin-free media or media containing 100nM insulin the
neurons were ﬁxed with 4% paraformaldehyde for 10 min-
utes. Immunohistochemistry was performed with SMI-312
(Covance,Emeryville,CA),apan-axonalmarker,tovisualize
neurites and counterstained with nuclear marker, Hoechst
33342 (Invitrogen). Coverslips were mounted on slides and
imaged. Neurite outgrowth area was quantiﬁed using Image
J. A stereological grid was superimposed on images of the
cultures,andthenumberofneuritescrossingexactlythrough
intersections of the grid was counted, as was the number of
neuronal cell bodies producing neurites. Six coverslips per
group were counted, and the neurite area per neuron was
calculated according to the following equation [35]:

neurite intersections
total grid intersections

×total grid area
neurons extending neurites
= neurite area

μm2
per neuron.
(1)
2.7. Statistical Analysis. A l ld a t aw e r ee x p r e s s e da sm e a n s
± standard error of the mean. Data were analyzed using a
Student’s t-test or 2-factor analysis of variance (ANOVA).
ANOVAs were followed up with post hoc comparisons using
Fisher’s least signiﬁcance diﬀerence where appropriate. A P
value < .05 was considered statistically signiﬁcant.
3. Results
3.1. IRS2 Is the Predominant IRS Isoform in the DRG. RT-
PCR was used to determine which mRNAs encoding IRS
isoforms were expressed in lumbar DRG from young adult
C57Bl/6 mice. Comparisons of mRNA levels for the 4
diﬀerent IRS isoforms in the DRG of nondiabetic C57Bl/6
mice revealed that IRS2 mRNA is abundantly expressed
within the lumbar DRG (Figures 1(a) and 1(b)). In fact,
IRS2 mRNA was expressed nearly 27-fold higher relative
to IRS1. In comparison, both IRS3 and IRS4 mRNAs were
barely detectable in relation to IRS1 (Figures 1(a) and
1(b)). Western blots of DRG from nondiabetic C57Bl/6 mice
showed that both IRS1 and IRS2 proteins were detectable
in the DRG (Figures 1(c) and 1(d)). Together, these results
suggest that insulin signals may be mediated through IRS
substrates in the DRG and IRS2 is expressed at much higher
levels similar to other neural tissues [20, 36–38].
Because IRS2 was expressed at higher levels than other
IRSisoforms,wefocusedonIRS2expressionandsignalingin
DRG neurons. Characterization of IRS2 expression patterns
in the lumbar DRG revealed widespread IRS2 immunore-
activity throughout the ganglia (Figures 2(a) and 2(d)).
IRS2-immunoreactivity was predominantly observed in the
cytoplasm of neurons and not in satellite cells or Schwann
cells (Figures 2(a) and 2(d)). Accordingly, identiﬁcation of
sensory neuron populations using antibodies to neuroﬁla-
mentheavychain(NF-200,myelinatedneurons,Figure 2(b))
andperipherin(unmyelinatedneurons,Figure 2(e))revealed
that IRS2 was expressed by a majority of DRG neurons, and
theseIRS2-positiveneuronsincludedbothunmyelinatedand
myelinated neuronal populations (Figures 2(b), 2(c), 2(e),
and 2(f)).
3.2. Diabetes Elevates IRS2 Serine Phosphorylation in Mouse
DRG. To determine whether IRS2 in the DRG is prone4 Experimental Diabetes Research
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Figure 1: IRS isoform expression in murine lumbar DRG. IRS isoforms were examined using RT-PCR ((a) and (b)) and Western blot
((c) and (d)). (a) RT-PCR was performed on adult C57Bl/6 mouse lumbar DRG (n = 3 mice) and comparisons were made among IRS1,
IRS2, IRS3, and IRS4. GAPDH was used as the housekeeping gene. ΔCt values for IRS2 were signiﬁcantly lower than any other isoform. (b)
Analysis of IRS mRNA levels that were normalized to IRS1 mRNA levels revealed that IRS2 mRNA expression was 27-fold higher than IRS1
in the DRG. ∗denotes P<. 05 n = 3 mice. ((c) and (d)) Representative Western blots of IRS1 and IRS2 protein in mouse lumbar DRG.
Equal amounts of protein (20μg) were loaded for each lane and samples were separated on 4–15% tris-glycine gel. Both IRS1 (c) and IRS2
(d) proteins were readily detectable. All mice were 8-week-old nondiabetic C57Bl/6 males.
to diabetes-induced elevations in serine phosphorylation
similar to other peripheral tissues, DRG neurons from type
2 diabetic and nondiabetic mice were cultured without
insulin for 3 days and then harvested for Western blot
analysis. Membranes were probed with antibodies selective
for pSer(731)IRS2 and then stripped and probed for total
IRS2(Figure 3(a)).QuantiﬁcationofpSer(731)IRS2normal-
ized to total IRS2 revealed that IRS2 serine phosphorylation
was signiﬁcantly increased in neurons from diabetic ob/ob
mice compared to their nondiabetic controls (P<. 05,
Figure 3(a)). Moreover, similar elevations in pSer(731)IRS2
were observed in freshly harvested DRG neurons after 6
weeks of STZ-induced type 1 diabetes in C57Bl/6 mice
(P<. 05, Figure 3(b)). These results reveal that IRS2
phosphorylation of serine residues is elevated in multiple
models of diabetes and, like other peripheral tissues, this
serine phosphorylation could lead to suppressed insulin
signaling in DRG neurons.
To investigate whether the elevated serine phosphory-
lation of IRS2 observed in DRG neurons harvested from
diabetic mice was possibly caused by the elevated glucose
levels,culturesfromnondiabeticcontrolanimalsweregrown
in hyperglycemic conditions (25mM glucose) for 3 days
and pSer(731)IRS2 levels were quantiﬁed. Results from these
experiments revealed that pSer(731)IRS2 was not elevated
in hyperglycemic cultures as compared to control cultures
grown in 10mM glucose (P>. 05 Figure 3(c)). Thus,
short-term elevations in glucose levels do not appear to
modify serine phosphorylation of IRS2, suggesting that the
mechanisms responsible for this eﬀect are not simply due to
elevated glucose.
It has been proposed that elevated serine phospho-
rylation of IRS proteins can lead to increased protein
degradation of IRS. Thus, degradation of IRS proteins may
also contribute to insulin resistance [39]. To address this
possibility, we quantiﬁed total IRS2 expression in neuronal
cultures from ob/ob diabetic mice and normalized them to
the housekeeping protein actin. This analysis revealed that
total IRS2 expression appeared to be decreased in DRG
cultures from diabetic ob/ob mice although this decrease was
not statistically signiﬁcant (P>. 05, Figure 4(a)). However,
this ﬁnding is consistent with the view that elevated IRS2
degradation may play a role in diminished insulin signaling.
One alternative possibility for decreased insulin signaling
is a downregulation of the insulin receptor (IR) in DRG of
diabeticob/obmice.Toexaminethispossibility,wemeasured
total IR protein levels in DRG cultures from diabetic ob/ob
mice. There were no signiﬁcant diﬀerences in IR levels
between DRG cultures from diabetic ob/ob mice and cultures
from nondiabetic mice (P>. 05, Figure 4(b)).Experimental Diabetes Research 5
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Figure 2: IRS2 protein expression pattern in murine lumbar DRG. Fluorescence immunohistochemistry was used to examine IRS2
expression in adult C57Bl/6 mouse lumbar DRG. ((a) and (d)) Photomicrographs of IRS2 immunoreactivity in DRG neurons. IRS2 was
expressed in most neurons of the DRG in mice. ((b) and (e)) Photomicrographs of the same sections stained with antibodies to NF-200 (b),
which labels large, myelinated neurons in the DRG or peripherin (e), which labels unmyelinated small DRG neurons. ((c) and (f)) Merged
images of IRS2 and NF-200 (c) labeling illustrate that many IRS2-positive neurons also express NF-200, suggesting that many IRS2-positive
neurons are large myelinated neurons. Similarly, merged images of IRS2 and peripherin (f) labeling illustrate that many IRS2-positive
neurons coexpress peripherin, suggesting that many IRS2-positive neurons are small unmyelinated neurons. Scale bar = 100μm.
3.3. Insulin-Stimulated Akt Activation Is Blunted in DRG
N e u r o n sf r o mD i a b e t i cM i c e .Akt is a serine kinase that
is one of the major downstream mediators activated in
insulin signaling in both peripheral tissues and neurons
[16, 24]. In neurons, neurotrophic factor activation of the
Akt pathway has been shown to promote survival and
growth of neurons [40, 41]. In its activated form, Akt is
phosphorylated (pAkt) on serine residue 473, and pAkt
is decreased in settings of insulin resistance [42]. Here,
DRG from diabetic ob/ob and control mice were grown
in insulin-free media for 3 days and then stimulated with
100nM insulin for 15 minutes. Cultures were then harvested
for Western blot analysis to determine Akt activation in
response to insulin. No signiﬁcant diﬀerences were observed
in baseline levels of Akt activation between diabetic and
nondiabetic mice. Insulin signiﬁcantly elevated activated
pSer(473)Aktinculturesfrombothnondiabetic anddiabetic
mice(P<. 05,Figure 5).However,Aktactivationinresponse
to insulin was signiﬁcantly lower in cultures from diabetic
ob/ob mice as compared to nondiabetic controls (P<. 05,
Figure 5),suggestingthattheinsulinsignalingpathwayisnot
being activated appropriately in the DRG of diabetic ob/ob
mice.
3.4. Insulin-Stimulated Neurite Outgrowth Is Diminished in
DRG Neurons from Diabetic Mice. One common feature
of neurotrophic factors is their ability to stimulate neurite
outgrowth in culture. Insulin increases the percentage of
neurons that produce neurites and promotes overall growth
of neurites in culture [43–45]. Here, neurite outgrowth in
response to insulin supplementation was used to determine
whether suppressed insulin signaling correlated with alter-
ations in neurite outgrowth. DRG cultures from diabetic
ob/ob mice and nondiabetic controls were grown in insulin-
free media or media supplemented with 100nM insulin.
After ﬁve days, the cultures were ﬁxed and stained with SMI-
312, a pan-axonal marker (Figures 6(a)–6(d)). Quantiﬁca-
tion of cultures harvested from nondiabetic and diabetic
ob/ob mice revealed that neurite outgrowth was signiﬁcantly
elevated in nondiabetic cultures following insulin supple-
mentation (P<. 05, Figures 6(a) and 6(c)). In contrast,
insulin supplementation did not aﬀect neurite outgrowth6 Experimental Diabetes Research
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Figure 3: pSer(731)IRS2 is elevated in DRG neurons from type 1 and type 2 diabetic mice. Protein was harvested from adult mouse DRG
culture from diabetic ob/ob and nondiabetic mice (a), freshly isolated DRG from STZ-injected diabetic and nondiabetic C57Bl/6 mice (b),
and from DRG neurons grown in hyperglycemic and control conditions (c). Western blots were performed using antibodies that recognized
phosphorylated ser731 resides on IRS2, and levels of Ser(731)IRS2 were normalized to total IRS2. (a) Comparisons of pSer(731)IRS2 levels
in nondiabetic and diabetic ob/ob mice revealed a signiﬁcant increase in pSer(731)IRS2 levels in diabetic mice. ∗denotes P<. 05 versus
nondiabetics. n = 6 for nondiabetic mice and n = 7 for diabetic mice. (b) Diabetes was induced in 8-week-old C57Bl/6 male mice with
STZ, and diabetes was allowed to progress for 6 weeks. Similar to ob/ob diabetic mice, pSer(731)IRS2 levels were signiﬁcantly elevated in
STZ-injected diabetic mice. ∗denotes P<. 05 versus nondiabetics. n = 5 for nondiabetic mice and n = 8 for diabetic mice. (c) DRG neurons
from nondiabetic animals were grown in 10mM (control) and 25mM (hyperglycemic) glucose concentrations. There was no signiﬁcant
change in IRS2 serine phosphorylation levels between groups. n = 6 for 10mM glucose and n = 7f o r2 5m Mg l u c o s e .Experimental Diabetes Research 7
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Figure 4: Total IRS2 and IR protein levels in mouse lumbar DRG. Protein was harvested from adult mouse DRG culture from diabetic ob/ob
and nondiabetic mice. Western blots were performed using antibodies that recognized total IRS2 (a) or IR β subunit levels (b). In both
cases protein levels were normalized to actin. (a) Total IRS2 levels were slightly decreased in diabetic ob/ob mice although this trend was not
statistically signiﬁcant (P>. 05). n = 7 for nondiabetic mice and n = 7 for diabetic mice. (b) IR β subunit protein levels were not statistically
diﬀerent between diabetic and nondiabetic mice (P>. 05). n = 5 for nondiabetic mice and n = 6 for diabetic mice.
in cultures from diabetic ob/ob mice. These diﬀerences
suggest that cultures from diabetic ob/ob mice have impaired
responses to insulin related to neurite outgrowth, a ﬁnding
that is consistent with the hypothesis that insulin-signaling
pathways in DRG neurons may be impaired by diabetes.
4. Discussion
The current study demonstrates that, similar to other neural
tissues, IRS2 appears to be the predominant isoform of IRS
in DRG neurons. Furthermore, insulin signaling in DRG
neurons from diabetic mice undergoes similar modiﬁcations
that have been proposed to underlie insulin resistance in
adipose and muscle. These signaling alterations are consis-
tent with blunted responses of sensory neurons to insulin
stimulation, including diminished activation of downstream
molecules and morphological changes. Collectively, these
results provide an important step towards understanding
how abnormalities in insulin signaling may impact sensory
neurons and may also contribute to the development and/or
progression of diabetic neuropathy.
Although insulin resistance is a major focus in type
2 diabetes associated with adipose and muscle tissue, our
understanding of the eﬀects of reduced insulin support to
sensory neurons is surprisingly lacking. A number of studies
have reported expression patterns of the insulin receptor
and IGF-1 receptor in DRG, but little is known about
the expression of IRS isoforms in DRG. Previous studies
reported that the insulin receptor is expressed primarily by
small nociceptive unmyelinated neurons [46–48]. Similar
expression patterns were described for the IGF-1 receptor
[49], suggesting that insulin and IGF-1 may preferentially
modulate small nociceptive neurons in the DRG [47]. In the
current study, IRS2 protein appears to be expressed by both
small and large DRG neurons, suggesting that insulin and/or
IGF-1 may support a broader scope of neuronal subtypes
than previously thought. Additionally, several reports have
documented IRS as key docking proteins in many signaling
cascades other than insulin, including neurotrophins such as
brain-derived neurotrophic factor [4, 50, 51].
Studies are currently underway to determine if changes
in IRS serine phosphorylation also lead to altered IGF1 sig-
naling. IRS proteins are a major component of both insulin
and IGF1 pathways, so it is possible that the reductions in
insulin signaling through IRS serine phosphorylation may
also aﬀect proper IGF1 function. It will be important to
identify these relationships, as a better understanding of
how IRS proteins integrate trophic signals may shed light
on mechanisms associated with neurotrophin deﬁciency in
diabetic neuropathy [52]. Finally, although the current study
focused primarily on IRS2, IRS1 was clearly detectable in the
DRG. It is plausible that DRG neurons can utilize multiple
IRS proteins to signal, and compensation and cooperation
between IRS proteins likely exist in the DRG and should be
considered in future investigations.
Schwann cell dysfunction leading to demyelination,
decreased neurotrophic support, and altered protection of
neurons is a known factor in the pathogenesis of DN [53].8 Experimental Diabetes Research
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Figure 5: Diabetes decreases insulin-stimulated Akt activation in DRG neurons. Primary cultures of lumbar DRG neurons from ob/ob
diabetic mice and nondiabetic controls were stimulated with 100nM insulin for 15 minutes and harvested for Western blot. Membranes
were probed for activated Akt (pSer(473)Akt) and normalized to total Akt levels. Insulin signiﬁcantly increased Akt activation in both
nondiabetic and diabetics cultures (∗P<. 05). In contrast, insulin-stimulated Akt activation in cultures from diabetic ob/ob mice was
signiﬁcantly suppressed in comparison to nondiabetic controls (†P<. 05). There were no signiﬁcant diﬀerences in baseline pAkt levels
between nondiabetic and diabetic mice. ∗ and † denote P<. 05; n = 5 for nondiabetic without insulin, n = 6 for nondiabetics with insulin,
n = 6 for diabetics without insulin, and n = 6 for diabetics with insulin.
Schwann cells express insulin receptors [54]; however, the
docking protein proﬁle has not been completely character-
ized. In this study, we did not observe IRS2 expression in
Schwann cells, raising the possibility that insulin signaling in
SchwanncellsmaybemediatedthroughanotherIRSisoform
or an additional docking protein such as, growth factor
receptor-bound protein 2 (Grb2), Grb2-associated binding
protein 1 (GAB1), or src homology 2 domain-containing
transforming protein 1 (SHC1).
OneinterestingﬁndingfromthisstudywasthatIRS2ser-
ine phosphorylation was increased in DRG from both type
1 and type 2 diabetic animals. This result was not entirely
surprising as a growing body of literature has documented
altered insulin responses in type 1 diabetic patients [55–
58]. Most recently, Schauer et al. demonstrated that type 1
patients are insulin resistant compared to nondiabetic sub-
jects and that the degree of insulin resistance correlated with
cardiovascular disease risk [56]. This suggests that mecha-
nisms associated with insulin resistance thought to be exclu-
sive to type 2 diabetes may also be at work in type 1 diabetes.
In the current study, experiments were carried out in
vitro to determine whether elevated glucose may underline
the increases in serine phosphorylation of IRS2. At this
point, our results do not support this view, as we saw
no change in serine phosphorylation of IRS2 in neurons
grown in high glucose. A failure to see insulin signaling
changesinculturesexposedtoabnormallyhighglucoselevels
could be a result of the short time frame, such that agents
associated with hyperglycemia and increased IRS serine
phosphorylation,includingadvancedglycationendproducts
and reactive oxygen species, did not suﬃciently alter the
stress kinase activity level. Further research is required to
determine the interplay of DRG IRS serine phosphorylation,
hyperglycemia, and type 1 diabetes.
If the eﬃcacy of insulin signaling does indeed play an
important role in DRG function, it is reasonable to propose
that factors common to both diabetes models could play
an important role in modulating IRS2 signaling regardless
of available insulin levels. In that vein, chronic inﬂam-
mation, increased free fatty acids, and elevated oxidative
stress associated with diabetes inhibit insulin signaling by
increasing serine phosphorylation of IRS1 in muscle and
adipose tissue [15, 16, 21, 22, 24, 27–30, 59–61]. These
various cellular stressors drive IRS serine phosphorylationExperimental Diabetes Research 9
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Figure 6:Diabetesdecreasesinsulin-stimulatedneuriteoutgrowthinDRGneurons.PrimaryculturesoflumbarDRGneuronsfromdiabetic
ob/ob and nondiabetic mice were grown in either insulin-free media or media containing 100nM insulin for 5 days. Neurites were then
stained with SMI 312, a pan-axonal marker. Neurite area was quantiﬁed using a stereological grid applied overtop photomicrographs of
cultured wells. Photographs of representative wells are shown on the top panel: (a) nondiabetics without insulin (n = 5), (b) diabetics
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by activating serine/threonine kinases. Evidence has targeted
several kinases involved in this pathway, including inhibitor
of kappa B kinase b (IKKb), c-Jun N-terminal kinase (JNK),
mammalian target of rapamycin (mTOR), and glycogen syn-
thase kinase-3β (GSK-3β)[ 16, 17, 27]. Further reports have
shown that both IRS1 and IRS2 have a JNK-binding motif
[16, 25] and that JNK and GSK-3β knockout mice display
increased insulin sensitivity [60, 62]. In addition, rapamycin,
an mTOR inhibitor, has been shown to improve insulin
sensitivity in an in vivo h u m a ns t u d ya n dan e u r o n a lc e l l
line [24, 63]. Moreover, antioxidant or anti-inﬂammatory
approaches can decrease stress kinase activity, leading to
improved insulin action in muscle [42, 64]. These studies
provide important links between inﬂammation, oxidative
stress and insulin signaling, and it will be important to
determine if these relationships exist and are relevant to
sensory nerve dysfunction.
AlthoughitislikelythattheinhibitoryeﬀectofIRSserine
phosphorylation may be more dependent on the number
of residues involved than a speciﬁc phosphorylation site
[27, 65, 66], the question of how IRS serine phosphorylation
may be aﬀecting insulin signaling is not clear. Several
mechanisms have been proposed, including dissociation
from either the insulin receptor or plasma membrane,
increased IRS proteosame degradation, interference with
binding of downstream mediators, and ﬁnally, decreased
tyrosine phosphorylation of the IRS protein [27]. Our
ﬁndingthatIRS2appearstobeslightlydecreasedinneuronal
cultures from diabetic ob/ob mice is consistent with the
idea that elevated serine phosphorylation can lead to IRS
degradation, thus limiting the ability of insulin to stimulate
downstream eﬀectors.
In addition to eﬀects of insulin in the peripheral nervous
system, insulin signaling in the central nervous system
(CNS) is gaining considerable attention. Insulin is known to
promote learning and memory [8], metabolic homeostasis
[14], and have eﬀects on aging [67]. Consequently, CNS
insulin resistance has been shown to play a critical role in the
development of Alzheimer’s disease [68], Parkinson’s disease
[69], and metabolic syndrome [70]. It is now becoming
evident that insulin resistance is not restricted to muscle
and adipose tissue but that it also occurs in nervous
tissue and can potentially be detrimental to proper neuron
function.
5. Conclusion
The current study provides evidence that IRS proteins are
expressed in the DRG and could play an important role
in the ability of insulin to support peripheral neurons.
Elevated serine phosphorylation of IRS proteins is a major
contributing mechanism underlying insulin resistance in
muscle and adipose tissue. Our results support a similar
mechanism of insulin-signaling disruption within DRG neu-
rons, and this modulatory step should be considered as an
additional component contributing to diabetic neuropathy.
Future studies should address mechanisms that can promote
insulin sensitivity in sensory neurons, as these may be
an avenue to develop therapeutic interventions that could
improve sensory nerve function in both type 1 and type 2
diabetic patients.
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